Saima May Sidik is a freelance science journalist based in Somerville, Mass. Follow her on Twitter @SaimaMaySidik
Ozempic and Mounjaro Aren’t the Same. Here’s How Weight-Loss Drugs Compare
A plethora of new weight-loss drugs are now available in the U.S., but they aren’t necessarily the same. Here’s a guide to the latest GLP-1 receptor agonists
Newfound Stem Cell Might Explain How Breast Cancer Spreads to the Spine
New research in mice suggests that a stem cell involved in backbone development might help tumors from other parts of the body move to the spine
Beyond Ozempic: New Obesity Drugs Could Be Cheaper and Even More Effective
Hormone mimics offer advantages even beyond those of the potent weight-loss shots on the market now
Death Rates among Black People in the U.S. Are Rising after Falling
Researchers hope their work on racial health disparities will be a “call to action”
World’s Deadliest Mushroom May Now Have an Antidote
A CRISPR gene-editing technique might have finally cracked the mystery of how death cap mushrooms kill and revealed a possible antidote
Dietary Restriction Works in Lab Animals, but It Might Not Work in the Wild
Scientists looking outside typical lab conditions find some surprises when examining the link between eating less and living longer
The Risk of Heart Disease after COVID
Some studies suggest that the risk of cardiovascular problems, such as a heart attack or stroke, remains high even many months after a SARS-CoV-2 infection clears up
The Hunt for Drugs for Mild COVID
People who are unlikely to develop severe COVID-19 have no widely approved medications to ease the illness
New COVID Drugs Face Delays as Trials Get Harder to Do
The success of vaccines has reduced the pool of people available for studies, among other factors
Pollen Grains Carry Hundreds of Plant Viruses
“Sexually transmitted” plant viruses may be on the rise because of agricultural activity
COVID Vaccines plus Infection Can Lead to Months of Immunity
New research counters high-profile claims that people who had COVID don’t benefit from vaccination
Vaccines Remain Effective against BA.2, but Protection from Infection Wanes over Time
Such protection declines within months of the mRNA COVID vaccines’ third dose. Yet the vaccines continue to ward off severe disease
Common Antidepressant Slashes Risk of COVID Death
Fluvoxamine is both inexpensive and highly effective at preventing mild COVID-19 from turning severe